The mean platelet volume (MPV) was significantly higher in the control group (10.13±1.09) than in the OSAS group (7.98±1.32) (p
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Aim: The objective of this study was to investigate the possibility of a relationship between the value of the platelet mass index and obstructive sleep apnea syndrome (OSAS) and to compare biochemical parameters among comorbidity groups in OSAS patients.Materials and Methods: The patients were divided into two groups; the patient group consisted of patients who had previously presented to the emergency department of our hospital and were diagnosed with OSAS through polysomnography, while the control group included individuals who had no diagnosed chronic diseases.The patients in the OSAS group were further divided into subgroups of patients with diabetes, diabetes + hypertension, diabetes + hyperlipidemia, diabetes + cardiovascular disease, diabetes + hypertension + hyperlipidemia, hyperlipidemia, cardiovascular disease, and hypertension.
📊
Temel Bulgular & Veri:Results: The mean BMI value was statistically significantly higher in OSAS patients than in with patients of the control group (24.28±1.00 vs 29.73±2.51 kg/m2).
💡
Sonuç & Katkı:The mean platelet volume (MPV) was significantly higher in the control group (10.13±1.09) than in the OSAS group (7.98±1.32) (p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Aim: The objective of this study was to investigate the possibility of a relationship between the value of the platelet mass index and obstructive sleep apnea syndrome (OSAS) and to compare biochemical parameters among comorbidity groups in OSAS patients.Materials and Methods: The patients were divided into two groups; the patient group consisted of patients who had previously presented to the emergency department of our hospital and were diagnosed with OSAS through polysomnography, while the control group included individuals who had no diagnosed chronic diseases.The patients in the OSAS group were further divided into subgroups of patients with diabetes, diabetes + hypertension, diabetes + hyperlipidemia, diabetes + cardiovascular disease, diabetes + hypertension + hyperlipidemia, hyperlipidemia, cardiovascular disease, and hypertension. Physical examination, complete blood count, and biochemical test outcomes of both groups as well as polysomnography data of the patient group were evaluated retrospectively. Results: The mean BMI value was statistically significantly higher in OSAS patients than in with patients of the control group (24.28±1.00 vs 29.73±2.51 kg/m2). The mean platelet volume (MPV) was significantly higher in the control group (10.13±1.09) than in the OSAS group (7.98±1.32) (p
🔖
Bu Makaleye Atıf Yap
SEYHANLI, E. S., YASAK, İ. H. (2022). Levels of Total Platelet Mass in Patients Admitted to EmergencyDepartment and Diagnosed with Obstructive Sleep Apnea Syndrome. Eurasian Journal of Emergency Medicine, Cilt: 20 - Sayı: 2, 107–112. https://ajindex.com/articles/507931
McNicholas WT, Bonsigore MR; Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J. 2007;29:156-78
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230-5
Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, et al. Populationbased study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med. 1997;157:1746-52
Kheirandish-Gozal L, Kim J, Goldbart AD, Gozal D. Novel pharmacological approaches for treatment of obstructive sleep apnea in children. Expert Opin Investig Drugs. 2013;22:71-85
American Academy of Sleep Medicine. Obstructive sleep Apnea. Illinois: American Academy of Sleep Medicine 2008
Badimon L, Padró T, Vilahur G. Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. Eur Heart J Acute Cardiovasc Care. 2012;1:60- 74
Kamath S, Blann AD, Lip GY. Platelet activation: assessment and quantification. Eur Heart J. 2001;22:1561-71
Malerba M, Olivini A, Radaeli A, Ricciardolo FL, Clini E. Platelet activation and cardiovascular comorbidities in patients with chronic obstructive pulmonary disease. Curr Med Res Opin. 2016;32:885-91
Akyol S, Çörtük M, Baykan AO, Kiraz K, Börekçi A, Şeker T, et al. Mean platelet volume is associated with disease severity in patients with obstructive sleep apnea syndrome. Clinics (Sao Paulo). 2015;70:481-5
Topcuoglu OB, Afsar GC, Sarac S, Oruc O, Kuyucu T. In the absence of comorbidities mean platelet volume is not a severity indicator in OSAS. Eur J Gen Med. 2016;13:134-8
Girgin R, Cinar O, Bulut E, Akduman B, Mungan NA. The Role of the Platelet Mass Index (PMI) as a New Prognostic Factor in Fournier’s Gangrene. African Journal of Urology. 2018;24:226-32
Atan D, Sazak Kundi FC, Özcan KM, Dere H. The Relationship Between Platelet Count and Mean Platelet Volume With Obstructive Sleep Apnea Syndrome. Kulak Burun Bogaz Ihtis Derg. 2015;25:289-94
Dikbas O, Erten N, Kucuker F, Aksehirli Yilmaz O. Relationship of Potential Inflammatory Markers Namely Neutrophile Lymphocyte ratio and Platelet Lymphocyte ratio With the Severity of Obstructive Sleep Apnea. Turk J Diab Obes/Türk Diya